DNAL1 and melanoma: The immunogenicity of PRAME has long been found in melanoma (LaVoy et al. 25), while the immunogenic KK-LC-1 peptide restricted by HLA-B62 and HLA-A2 was discovered in lung adenocarcinoma (Fukuyama et al. 19).